Бронхіальна астма - Міністерство охорони здоров'я України

829. Rahimi R, Nikfar S, Abdollahi M. Meta-analysis finds use of inhaled corticosteroids during pregnancysafe: a systematic meta-analysis review. Human & Experimental Toxicology 2006;25(8):447-52.830. Källén B. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft PalateCraniofac J 2003;40(6):624-8.831. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. Maternal corticosteroiduse and orofacial clefts. Am J Obstet Gynecol 2007;197(6):585 e1-7; discussion 683-4, e1-7.832. Bakhireva LN, Schatz M, Chambers CD. Effect of maternal asthma and gestational asthma therapy onfetal growth. Journal of Asthma 2007;44(2):71-6.833. Twaites BR, Wilton LV, Shakir SA. Safety of zafirlukast: results of a postmarketing surveillance studyon 7976 patients in England. Drug Safety 2007;30(5):419-29.834. Wensley D, Silverman M. Peak flow monitoring for guided selfmanagement in childhood asthma: arandomized controlled trial. Am J Respir Crit Care Med 2004;170(6):606-12.835. Burkhart PV, Rayens MK, Revelette WR, Ohlmann A, McCoy K, Shade DM, et al. Improved healthoutcomes with peak flow monitoring for children with asthma. J Asthma 2007;44(2):137-42.836. McCoy K, Shade DM, Irvin CG, Mastronarde JG, Hanania NA, Castro M, et al. Predicting episodes ofpoor asthma control in treated patients with asthma. J Allergy Clin Immunol 2006;118(6):1226-33.837. Nuijsink M, Hop WC, Sterk PJ, Duiverman EJ, de Jongste JC. Long-term asthma treatment guided byairway hyperresponsiveness in children: a randomised controlled trial. Eur Respir J 2007;30(3):457-66.838. de Jongste JC, Carraro S, Hop WC, Group CS, Baraldi E. Daily telemonitoring of exhaled nitric oxideand symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med 2009;179(2):93-7.839. Fritsch M, Uxa S, Horak F, Putschoegl B, Dehlink E, Szepfalusi Z, et al. Exhaled nitric oxide in themanagement of childhood asthma: a prospective 6-months study. Pediatr Pulmonol 2006;41(9):855-62.840. Pijnenburg MW, Hofhuis W, Hop WC, De Jongste JC. Exhaled nitric oxide predicts asthma relapse inchildren with clinical asthma remission. Thorax 2005;60(3):215-8.841. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O’Connor GT, Morgan WJ, et al. Management ofasthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents andyoung adults: a randomised controlled trial. Lancet 2008;372(9643):1065-72.842. Covar RA, Szefler SJ, Zeiger RS, Sorkness CA, Moss M, Mauger DT, et al. Factors associated withasthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy ClinImmunol 2008;122(4):741-7.843. Fuhlbrigge AL, Weiss ST, Kuntz KM, Paltiel AD. Forced expiratory volume in 1 second percentageimproves the classification of severity among children with asthma. Pediatrics 2006;118(2):e347-55.844. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, et al. Clinical use of noninvasivemeasurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med2005;171(10):1077-82.845. Juniper EF, Gruffydd-Jones K, Ward S, Svensson K. Asthma Control Questionnaire in children:validation, measurement properties, interpretation. Eur Respir J 2010;36(6):1410-6.846. Bacharier LB, Guilbert TW, Zeiger RS, Strunk RC, Morgan WJ, Lemanske Jr RF, et al. Patientcharacteristics associated with improved outcomes with use of an inhaled corticosteroid in preschoolchildren at risk for asthma. J Allergy Clin Immunol 2009;123(5):1077-82.847. Busse WW, Pedersen S, Pauwels RA, Tan WC, Chen YZ, Lamm CJ, et al. The Inhaled SteroidTreatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: Effectiveness ofearly intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 2008;121(5):1167-74.848. Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers withrecurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 2009;123(3):e519-25.849. Kerwin EM, Pearlman DS, de Guia T, Carlsson LG, Gillen M, Uryniak T, et al. Evaluation of efficacyand safety of budesonide delivered via two dry powder inhalers. Curr Med Res and Opin 2008;24(5):1497-510.850. Knuffman JE, Sorkness CA, Lemanske RF, Jr., Mauger DT, Boehmer SJ, Martinez FD, et al.Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies inpediatric asthma. J Allergy Clin Immunol 2009;123(2):411-6.851. Kooi EMW, Schokker S, Marike Boezen H, de Vries TW, Vaessen-Verberne AAPH, van der Molen T,et al. Fluticasone or montelukast for preschool children with asthma-like symptoms: randomized controlledtrial. Pulm Pharmacol Ther 2008;21(5):798-804.265